SALT LAKE CITY , Sept. 29, 2022 /PRNewswire/ — We are pleased to announce that Provet ® has partnered with Sentrx TM Animal Treatment as the exclusive distributor representing the patented crosslinked Hyaluronic Acid BioHAnce® brand of products in Australia .
Effective September 28, 2022 Sentrx ophthalmology items: Ocunovis™ BioHAnce™ Gel Vision Drops , Oculenis™ BioHAnce™ Ocular Barrier Gel will be available through Provet ® to all authorized veterinary customers.
All Sentrx products feature patented and clinically proven BioHAnce technology of which millions of doses have been sold globally to veterinarians*. This partnership allows veterinarians in Sydney to prescribe the first plus only formulation with cross-linked hyaluronic acid (HA). The cross-linking of BioHAnce provides the longest lasting ocular lubrication on the market. That promotes consistency of the particular tear film and enhances the eye’s ability to maintain hydration.
“The benefits of topical hyaluronic acidity (HA) use are well known within the global veterinary ophthalmology community, so it is exciting in order to be launching the first HA-based eye drops with regard to companion animals in Quotes “, said Brian Segebrecht , Chief Executive Officer associated with Sentrx. “However, doing so along with BioHAnce is even more exciting. The particular patented cross-linking of BioHAnce™ only elevates the benefits of HA, and Sentrx continues to generate more and a lot more exciting clinical data supporting these advantages. ”
Sentrx Animal Care is committed to the well-being of companion creatures with novel ocular items that provide exceptional comfort. Additionally , Sentrx is dedicated to increased ophthalmologic education and research that helps serve the particular needs of the veterinary profession.
*Represents the various eye and wound care products under various brands globally that incorporated the corresponding version of the particular patented BioHAnce technology.
Learn more about these products plus support regarding Australia :
Provet, a subsidiary of Covetrus, is the leading animal health distribution company in Australasia. Established in 1982 by a small group of veterinarians, Provet has helped build the industry through commitment, initiative, and experience.
About SentrX ™
Animal Care, Inc.
SentrX is a veterinary medical device company that will develops and manufactures vet wound treatment and ophthalmic products intended for companion pets. SentrX transforms complex biotechnologies into easy-to-use care solutions that promote the long-term well-being associated with animals.
SentrX was founded on technology from the University of Utah and collaborates with a variety of veterinary academic institutions plus practicing veterinarians. The company’s unique combination of medicinal chemistry, bioengineering, and product manufacturing capabilities allow it to deliver cutting-edge pet care options.
SOURCE Sentrx Animal Care